Joule Therapeutics

What We Are About

To develop a revolutionary energy-activated therapeutic platform for cancer treatment.

A future where patients benefit from non-invasive, safer, and more efficacious cancer therapies—driven by innovation in energy-activated nanomedicine.

  • Innovation in therapeutic design

  • Scientific rigor

  • Improved patient-centered outcomes

Meet the Joule Therapeutics Team

James Hamby, Ph.D.

President & CEO

Hyllana Medeiros, Ph.D.

Cofounder

Amir Roshanzadeh

Cofounder

Prof. Sophia Lunt, Ph.D.

Cofounder
Scientific Advisor

Prof. Richard Lunt, Ph.D.

Cofounder
Scientific Advisor

Prof. Vincent Lavallo, Ph.D.

Cofounder
Scientific Advisor

Laura Cesa, Ph.D.

Advisor